Using continuous glucose monitoring for cardiac surgery patients
Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients
This study is testing if using continuous glucose monitoring can help people with type 2 diabetes and prediabetes have better blood sugar control and fewer complications after heart surgery compared to regular glucose checks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 68 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Kangbuk Samsung Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06275971 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Continuous Glucose Monitoring (CGM) systems in managing glycemic control and reducing surgery-related complications in patients undergoing elective cardiac surgery. It compares CGM to traditional glucose monitoring methods, such as arterial/venous blood sampling and Point-of-Care Testing (POCT). The study focuses on patients with type 2 diabetes and prediabetes, assessing their blood glucose levels before and after surgery. The goal is to determine if CGM can provide better outcomes for these patients.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old with type 2 diabetes or prediabetes awaiting elective cardiac surgery.
Not a fit: Patients undergoing emergency surgery or those with type 1 diabetes will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved glycemic control and reduced complications for cardiac surgery patients.
How similar studies have performed: Other studies have shown promising results with continuous glucose monitoring in various patient populations, suggesting potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects waiting for Elective Cardiac Surgery (CABG, Cardiac Valve Operation, Congenital heart anomaly surgery, aortic surgery, etc.) * Subjects over the age of 18 * Patients with type 2 diabetes * Patients with prediabetes 1. HbA1c 5.7% or more 2. fasting blood glucose 100 mg/dL or more 3. 2 hours 75g-OGTT 140 mg/dL or more Exclusion Criteria: * Emergency surgery patients * Patients performing co-operation other than cardiac surgery * Patients with type 1 diabetes * Total Pancreatectomy patients * Patients with high surgical severity (STS score of 8 or more or EURO score of 5 or more) * Patients who do not consent to the study * Severe patients who are deemed difficult to continue research during surgery (excluded at the researcher's discretion) 1. Cases where severe weight gain and severe edema occur after surgery 2. Cases where the surgery time is significantly longer than average 3. Cases where cardiopulmonary bypass is used more than once during surgery * Others who are deemed unsuitable for research progression at the researcher's discretion
Where this trial is running
Seoul
- Kangbuk Samsung Hospital — Seoul, Korea, Republic of (Recruiting)
Study contacts
- Study coordinator: Cheol-Young Park, MD, PhD
- Email: cydoctor68@gmail.com
- Phone: +82220011550
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.